Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Cooke

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Transplantation|September 28, 2002
Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD miceMartin Drage, Paola Zaccone, Jenny M Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Loss of invariant chain protects nonobese diabetic mice against type 1 diabetesRichard J Mellanby, Chad H Koonce, Anthony Monti, et al.
Journal of Biomedicine & Biotechnology|March 6, 2010
Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systemsPaola Zaccone, Oliver T Burton, Sarah Gibbs, et al.
The Journal of Clinical Investigation|February 4, 2009
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient miceDavid Bending, Hugo De la Peña, Marc Veldhoen, et al.
Plos One|January 20, 2016
Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine ProductionAriana Barbera Betancourt, Juliet L Emery, Asha Recino, et al.
Nature Medicine|June 4, 2009
Validated germline-competent embryonic stem cell lines from nonobese diabetic miceJennifer Nichols, Kenneth Jones, Jenny M Phillips, et al.
The Review of Diabetic Studies : RDS|October 7, 2009
Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populationsJenny M Phillips, Nicole M Parish, Tim Raine, et al.
European Journal of Immunology|May 19, 2010
Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigensOliver T Burton, Sarah Gibbs, Nigel Miller, et al.
Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.
Journal of Proteome Research|October 11, 2017
Metabolomics and Lipidomics Study of Mouse Models of Type 1 Diabetes Highlights Divergent Metabolism in Purine and Tryptophan Metabolism Prior to Disease OnsetSteven A Murfitt, Paola Zaccone, Xinzhu Wang, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Transplantation|September 28, 2002
Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD miceMartin Drage, Paola Zaccone, Jenny M Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Loss of invariant chain protects nonobese diabetic mice against type 1 diabetesRichard J Mellanby, Chad H Koonce, Anthony Monti, et al.
Journal of Biomedicine & Biotechnology|March 6, 2010
Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systemsPaola Zaccone, Oliver T Burton, Sarah Gibbs, et al.
The Journal of Clinical Investigation|February 4, 2009
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient miceDavid Bending, Hugo De la Peña, Marc Veldhoen, et al.
Plos One|January 20, 2016
Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine ProductionAriana Barbera Betancourt, Juliet L Emery, Asha Recino, et al.
Nature Medicine|June 4, 2009
Validated germline-competent embryonic stem cell lines from nonobese diabetic miceJennifer Nichols, Kenneth Jones, Jenny M Phillips, et al.
The Review of Diabetic Studies : RDS|October 7, 2009
Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populationsJenny M Phillips, Nicole M Parish, Tim Raine, et al.
European Journal of Immunology|May 19, 2010
Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigensOliver T Burton, Sarah Gibbs, Nigel Miller, et al.
Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.
Journal of Proteome Research|October 11, 2017
Metabolomics and Lipidomics Study of Mouse Models of Type 1 Diabetes Highlights Divergent Metabolism in Purine and Tryptophan Metabolism Prior to Disease OnsetSteven A Murfitt, Paola Zaccone, Xinzhu Wang, et al.
Pageof 11